ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,187Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1211

$562K Total Retail Price of All Prescriptions

Rank: 73 out of 1211

294 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 12,682 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
RANITIDINE HCL 870 826 1 45
PRAVASTATIN SODIUM 773 755 2 18
LISINOPRIL 629 606 3 6
CLOPIDOGREL 496 484 4 10
SIMVASTATIN 493 470 5 1
PLAVIX 430 422 6 14
METFORMIN HCL 406 387 7 27
ALENDRONATE SODIUM 351 348 8 60
METOPROLOL TARTRATE 345 331 9 4
IBUPROFEN 333 320 10 70
OMEPRAZOLE 328 300 11 20
ISOSORBIDE MONONITRATE 314 303 10 12 192
HYDROCHLOROTHIAZIDE 296 292 13 17
ATENOLOL 269 261 14 13
LEVOTHYROXINE SODIUM 259 259 15 22
MECLIZINE HCL 246 237 16 90
FUROSEMIDE 236 236 17 7
NAPROXEN 234 226 18 120
AMLODIPINE BESYLATE 193 184 19 2
CRESTOR 172 153 20 11
METOPROLOL SUCCINATE 170 162 21 5
DIOVAN 164 164 22 21
GLIPIZIDE 151 151 23 94
ADVAIR DISKUS 140 126 24 84
DONEPEZIL HCL 135 129 25 58
LOSARTAN POTASSIUM 123 117 26 12
WARFARIN SODIUM 119 119 27 8
ZOLPIDEM TARTRATE 109 107 28 32
DICLOFENAC SODIUM 104 104 29 117
LOVAZA 104 95 29 52
AMLODIPINE BESYLATE-BENAZEPRIL 103 99 31 46
GLYBURIDE 96 80 R 32 109
POTASSIUM CHLORIDE 95 91 33 19
LIDODERM 93 93 34 103
NITROSTAT 93 89 34 26
VOLTAREN 91 91 36 106
NITROGLYCERIN PATCH 88 81 37 55
DIOVAN HCT 87 85 38 35
SINGULAIR 84 81 39 102
KETOCONAZOLE 82 70 40 136
CARVEDILOL 78 78 41 3
NOVOLIN 70-30 76 76 42 137
GABAPENTIN 76 76 42 57
AZITHROMYCIN 74 69 44 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 70 45 199
CLONIDINE HCL 72 72 46 34
PROAIR HFA 70 68 47 125
CHOLESTYRAMINE 66 66 48 320
ENALAPRIL MALEATE 66 66 48 28
CILOSTAZOL 61 61 50 83
TAMSULOSIN HCL 55 55 51 62
PAROXETINE HCL 52 52 52 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.